tyloxapol has been researched along with Non-alcoholic Fatty Liver Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Deng, X; Feng, H; Li, Z; Peng, Y; Shen, B; Wang, Y; Zhang, Q; Zhao, L | 1 |
| Bao, G; Fu, M; Ji, X; Ma, Q; Ming, H; Wang, X; Wei, C | 1 |
| Cheng, J; Feng, H; Jin, M; Li, Z; Liu, G; Qin, H; Shen, B; Wang, Q; Zhao, L | 1 |
| Al-Dhabi, NA; Balakrishna, K; Darvin, SS; Esakkimuthu, S; Ignacimuthu, S; Pandikumar, P; Sivasankaran, K; Stalin, A; Toppo, E | 1 |
| Chi, G; Feng, H; Han, L; Li, Z; Shen, B; Tian, Y; Wang, Y; Wu, L; Zhang, Q | 1 |
| Baumgartner-Parzer, S; Buettner, C; Carli, F; Freudenthaler, A; Fürnsinn, C; Gastaldelli, A; Guerra, S; Hackl, MT; Helbich, TH; Krssak, M; Luger, A; Scherer, T; Schuh, CM; Zeyda, M | 1 |
| Bahirat, UA; Goel, RN; Nemmani, KV; Shenoy, RR | 1 |
7 other study(ies) available for tyloxapol and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Pterostilbene alleviated NAFLD via AMPK/mTOR signaling pathways and autophagy by promoting Nrf2.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Fatty Acids; Lipid Metabolism; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Signal Transduction; TOR Serine-Threonine Kinases | 2023 |
Digeda-4 decoction and its disassembled prescriptions improve dyslipidemia and apoptosis by regulating AMPK/SIRT1 pathway on tyloxapol-induced nonalcoholic fatty liver disease in mice.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 8; Dyslipidemias; Lipids; Liver; Mice; Non-alcoholic Fatty Liver Disease; PPAR alpha; Prescriptions; Proto-Oncogene Proteins c-bcl-2; Sirtuin 1; Sterol Regulatory Element Binding Protein 1 | 2023 |
Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways.
Topics: AMP-Activated Protein Kinases; Animals; Gene Expression Regulation; Hep G2 Cells; Humans; Inflammation; Iridoids; Lipids; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Palmitic Acid; Phosphatidylinositol 3-Kinases; Phosphorylation; Polyethylene Glycols; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |
Antihyperlipidemic and hepatoprotective effects of Gardenin A in cellular and high fat diet fed rodent models.
Topics: Animals; Cell Survival; Diet, High-Fat; Flavones; Gardenia; Hep G2 Cells; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Liver; Male; Non-alcoholic Fatty Liver Disease; Oleic Acid; Palmitates; Polyethylene Glycols; Protective Agents; Rats; Rats, Wistar | 2017 |
Morin reduces inflammatory responses and alleviates lipid accumulation in hepatocytes.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinase Kinases; Animals; Flavonoids; Hep G2 Cells; Hepatocytes; Humans; Hyperlipidemias; Inflammation; Lipid Metabolism; Mice; Non-alcoholic Fatty Liver Disease; Oleic Acid; Phosphorylation; Polyethylene Glycols; PPAR alpha; Protein Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2019 |
Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis.
Topics: Animals; Blood-Brain Barrier; Diet, High-Fat; Disease Models, Animal; Humans; Infusions, Intraventricular; Injections, Intraventricular; Leptin; Lipogenesis; Lipoproteins, VLDL; Liver; Male; Medulla Oblongata; Non-alcoholic Fatty Liver Disease; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Sympathectomy; Triglycerides; Vagus Nerve | 2019 |
APD668, a G protein-coupled receptor 119 agonist improves fat tolerance and attenuates fatty liver in high-trans fat diet induced steatohepatitis model in C57BL/6 mice.
Topics: Animals; Diet, High-Fat; Drug Interactions; Gastric Emptying; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Linagliptin; Male; Mesylates; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxadiazoles; Polyethylene Glycols; Pyrazoles; Pyrimidines; Receptors, G-Protein-Coupled; Tetrazoles; Thiazoles; Triglycerides | 2017 |